Silicon Valley Capital Partners Purchases 32,262 Shares of UnitedHealth Group Incorporated $UNH

Silicon Valley Capital Partners boosted its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 1,605.9% in the first quarter, Holdings Channel reports. The institutional investor owned 34,271 shares of the healthcare conglomerate’s stock after buying an additional 32,262 shares during the period. UnitedHealth Group accounts for approximately 0.9% of Silicon Valley Capital Partners’ holdings, making the stock its 28th largest position. Silicon Valley Capital Partners’ holdings in UnitedHealth Group were worth $9,273,000 as of its most recent SEC filing.

Other large investors have also recently modified their holdings of the company. Norges Bank bought a new stake in shares of UnitedHealth Group in the 4th quarter valued at about $4,376,167,000. T. Rowe Price Investment Management Inc. lifted its stake in shares of UnitedHealth Group by 141.9% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 4,109,029 shares of the healthcare conglomerate’s stock worth $1,356,432,000 after acquiring an additional 2,410,128 shares during the period. Cardano Risk Management B.V. increased its position in UnitedHealth Group by 864.4% during the 4th quarter. Cardano Risk Management B.V. now owns 2,523,700 shares of the healthcare conglomerate’s stock valued at $833,099,000 after purchasing an additional 2,262,006 shares during the period. Bank of America Corp DE lifted its position in shares of UnitedHealth Group by 21.8% in the 1st quarter. Bank of America Corp DE now owns 11,713,684 shares of the healthcare conglomerate’s stock worth $3,169,606,000 after purchasing an additional 2,097,859 shares during the period. Finally, Hsbc Holdings PLC increased its position in shares of UnitedHealth Group by 87.5% during the fourth quarter. Hsbc Holdings PLC now owns 3,916,041 shares of the healthcare conglomerate’s stock worth $1,294,367,000 after buying an additional 1,826,948 shares during the period. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

UNH opened at $421.48 on Friday. The company has a current ratio of 0.78, a quick ratio of 0.80 and a debt-to-equity ratio of 0.66. The company’s fifty day moving average price is $410.86 and its two-hundred day moving average price is $347.79. The company has a market cap of $382.76 billion, a price-to-earnings ratio of 27.12, a PEG ratio of 1.46 and a beta of 0.62. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $461.62.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share for the quarter, topping analysts’ consensus estimates of $4.94 by $1.44. The company had revenue of $112.03 billion for the quarter, compared to analyst estimates of $110.81 billion. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The firm’s revenue was up .4% compared to the same quarter last year. During the same quarter in the prior year, the business posted $4.08 EPS. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. On average, analysts expect that UnitedHealth Group Incorporated will post 19.71 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 23rd. Shareholders of record on Monday, June 15th were paid a dividend of $2.32 per share. This is a boost from UnitedHealth Group’s previous quarterly dividend of $2.21. The ex-dividend date was Monday, June 15th. This represents a $9.28 annualized dividend and a yield of 2.2%. UnitedHealth Group’s dividend payout ratio (DPR) is 59.72%.

Wall Street Analysts Forecast Growth

A number of analysts have commented on the stock. Sanford C. Bernstein reaffirmed an “outperform” rating on shares of UnitedHealth Group in a research report on Tuesday, July 21st. HC Wainwright set a $492.00 target price on UnitedHealth Group in a research report on Wednesday, May 27th. Cantor Fitzgerald reissued an “overweight” rating on shares of UnitedHealth Group in a research note on Thursday, June 11th. Bank of America reiterated a “buy” rating on shares of UnitedHealth Group in a research note on Monday, July 20th. Finally, Barclays raised their price target on shares of UnitedHealth Group from $429.00 to $441.00 and gave the stock an “overweight” rating in a report on Monday, July 20th. Two research analysts have rated the stock with a Strong Buy rating, twenty have issued a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $455.92.

UnitedHealth Group News Roundup

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth reported second-quarter revenue of $112.03 billion and adjusted EPS of $6.38, well above the $4.94 consensus estimate. Management also maintained 2026 EPS guidance of $19.50–$20.00, reinforcing expectations that profitability is recovering. UnitedHealth Just Gave Wall Street a Clearer Turnaround Signal
• Positive Sentiment: Improved margins and a lower medical cost ratio indicate that UnitedHealth’s cost-control initiatives are gaining traction after the company’s difficult 2025 performance. Continued share repurchases and a higher earnings outlook add support to the investment case. UnitedHealth’s Cost-Control Story is Gaining Momentum
• Positive Sentiment: Analyst sentiment has improved: Erste Group raised its 2026 EPS estimate to $19.85 from $18.33 and its 2027 estimate to $22.44 from $20.87, retaining a Buy rating. Another valuation update lifted fair value to $475.23 from $424.23, citing Q2 performance and better Medicare Advantage and Optum Health assumptions. UnitedHealth Group Stock Sees Fair Value Lift
• Neutral Sentiment: Brokerages currently give UNH a consensus “Moderate Buy” rating, suggesting constructive—but not unanimous—expectations for the recovery. UnitedHealth Given Moderate Buy Recommendation
• Negative Sentiment: Investors still face risks from commercial-insurance trends, Medicaid performance, regulatory scrutiny and elevated medical costs, including expenses related to surprise-billing dispute resolutions. These issues could limit the pace of the turnaround.

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.